Related Experiment Videos
Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem
Edward J Cone1, Reginald V Fant, Jeffrey M Rohay
1Pinney Associates, Bethesda, Maryland, USA.
Journal of Analytical Toxicology
|April 3, 2003
Summary
Most oxycodone-related deaths involved multiple drugs, not just oxycodone alone. This study highlights the complexity of attributing cause of death in poly-drug fatalities.
Area of Science:
- Forensic Toxicology
- Public Health
- Drug Abuse Epidemiology
Background:
- Oxycodone, particularly the OxyContin formulation, has been implicated in drug abuse fatalities.
- Accurate determination of the role of specific drugs in postmortem cases is crucial for public health.
- Existing data reporting systems may not fully capture the complexity of poly-drug abuse deaths.
Purpose of the Study:
- To establish a postmortem database of oxycodone-involved deaths.
- To evaluate the specific role of oxycodone and OxyContin in these fatalities.
- To categorize deaths based on drug abuse involvement and drug combinations using a standardized system.
Main Methods:
- Compiled a database of 1243 solicited postmortem cases from Medical Examiner and Coroner offices (1999-2002).
- Cases were included if death was opined to involve oxycodone; identification confirmed by toxicology and scene/witness evidence.
- Developed a categorization system based on the Drug Abuse Warning Network (DAWN) for drug abuse mortality.
Main Results:
- Of 1014 evaluated cases, 919 (90.6%) were drug abuse-related.
- Only 30 (3.3%) cases involved oxycodone as the sole reported chemical entity.
- The vast majority (889, 96.7%) of drug abuse cases involved multiple drugs, commonly combined with benzodiazepines, alcohol, cocaine, or other narcotics.
Conclusions:
- Oxycodone is frequently involved in drug abuse fatalities, but rarely as the sole contributing substance.
- Multiple drug abuse is a significant factor in oxycodone-related deaths, complicating cause of death attribution.
- A standardized system for reporting opioid mortality, acknowledging poly-drug involvement, is recommended for future studies.